3 Patents
- US121569032024Use of ADAMTS13 for Treating, Ameliorating And/or Preventing Vaso-occlusive Crisis in Sickle Cell Disease, Acute Lung Injury And/or Acute Respiratory Distress Syndrome
TAKEDA PHARMACEUTICAL COMPANY LIMITED
0 cites - US121280902024Methods of Prophylactic Treatment Using Recombinant VWF (rvwf)
Takeda Pharmaceutical Company Limited
0 cites - US120169042024Treatment of Gastrointestinal Bleeding in Patients with Severe Von Willebrand Disease by Administration of Recombinant VWF
Takeda Pharmaceutical Company Limited
0 cites